This study is looking at how effective and safe a treatment combining MDMA (3,4 Methylenedioxymethamphetamine) with Prolonged Exposure (a type of therapy) is for veterans with Post-Traumatic Stress Disorder (PTSD). You might be able to join if you are a veteran between 18 and 64 years old, have PTSD, and can speak and read English. The study will measure changes in your PTSD symptoms as rated by a clinician, from the start of the study up to four months after treatment. The current status of this study is unclear, but it plans to enroll between 10 and 20 veterans.

Study design

This is a randomized pilot study, meaning participants will be assigned by chance to receive different doses of MDMA. It plans to enroll between 10 and 20 U.S. veterans.

What's involved

You would commit to medication dosing, therapy sessions, follow-up sessions, completing evaluation instruments, and necessary phone calls. This includes twelve 90-minute Prolonged Exposure sessions over approximately three weeks, with some sessions occurring daily or every other day.

Compensation

Not stated in the trial record.

Follow-up

Your PTSD symptoms will be measured up to four months after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.